IMTRAPHARMA LTD, MOON LANE, United Kingdom

Shareholders

Name	Holding	Voting	Since

Ultimate Beneficial Owner

Name	Ownership	Country	Since

Financials

Key figures from annual accounts filings.

Convert to

2011

Profit / (loss): £14.6K

Key figures

Profit / (loss)

2011£14,613

2012£-2

2013£65,729

2014£253,628

2017—

2018—

2021—

2022—

2023—

Total assets

2011£14,615

2012£0

2013£65,731

2014£253,630

2017£713,455

2018£536,940

2021£451,595

2022£473,478

2023£384,061

Net Assets Liabilities

2011—

2012—

2013—

2014—

2017£713,455

2018£536,940

2021£451,595

2022£473,478

2023£384,061

Equity

2011—

2012—

2013—

2014—

2017£713,455

2018£536,940

2021£451,595

2022£473,478

2023£384,061

Current Assets

2011£65,550

2012£74,030

2013£128,025

2014£210,325

2017£490,784

2018£493,125

2021£204,955

2022£129,322

2023£387,114

Net Current Assets Liabilities

2011£14,511

2012£0

2013£64,792

2014£108,931

2017£524,238

2018£337,331

2021£161,810

2022£114,622

2023£383,144

Total Assets Less Current Liabilities

2011£14,615

2012£0

2013£65,731

2014£253,630

2017£715,990

2018£539,440

2021£451,595

2022£473,478

2023£384,061

Cash Bank On Hand

2011—

2012—

2013—

2014—

2017—

2018—

2021£204,504

2022£128,806

2023£387,114

Debtors

2011£26,893

2012£30,290

2013£22,038

2014£24,595

2017—

2018—

2021£451

2022£516

2023£300,590

Other Debtors

2011—

2012—

2013—

2014—

2017—

2018—

2021£451

2022—

2023£285,926

Creditors

2011—

2012—

2013—

2014—

2017£141,546

2018£155,794

2021£43,145

2022£14,700

2023£3,970

Other Creditors

2011—

2012—

2013—

2014—

2017—

2018—

2021£43,145

2022£14,700

2023£3,900

Investments Fixed Assets

2011—

2012—

2013£0

2014£144,229

2017—

2018—

2021£289,034

2022£357,293

2023—

Number Shares Allotted

2011—

20122

2013—

20142

2017—

2018—

2021—

2022—

2023—

Number Shares Issued Fully Paid

2011—

2012—

2013—

2014—

2017—

2018—

20212

20222

20232

Par Value Share

2011—

2012£1

2013—

2014£1

2017—

2018—

2021£1

2022£1

2023£1

Average Number Employees During Period

2011—

2012—

2013—

2014—

2017—

2018—

20211

20221

20231

Accrued Liabilities Not Expressed Within Creditors Subtotal

2011—

2012—

2013—

2014—

2017£2,535

2018£2,500

2021—

2022—

2023—

Accumulated Depreciation Impairment Property Plant Equipment

2011—

2012—

2013—

2014—

2017—

2018—

2021£5,163

2022£5,809

2023£7,010

Additions Other Than Through Business Combinations Property Plant Equipment

2011—

2012—

2013—

2014—

2017—

2018—

2021£1,937

2022—

2023£1,279

Called Up Share Capital

2011£2

2012£2

2013£2

2014£2

2017—

2018—

2021—

2022—

2023—

Cash Bank In Hand

2011£38,657

2012£43,740

2013£105,987

2014£185,730

2017—

2018—

2021—

2022—

2023—

Corporation Tax Payable

2011—

2012—

2013—

2014—

2017—

2018—

2021—

2022£70

2023£70

Creditors Due Within One Year

2011£51,039

2012£74,030

2013£63,233

2014£101,394

2017—

2018—

2021—

2022—

2023—

Depreciation Rate Used For Property Plant Equipment

2011—

2012—

2013—

2014—

2017—

2018—

2021£0

2022—

2023—

Fixed Assets

2011£104

2012£0

2013£939

2014£144,699

2017£191,752

2018£202,109

2021£289,785

2022£358,856

2023—

Increase From Depreciation Charge For Year Property Plant Equipment

2011—

2012—

2013—

2014—

2017—

2018—

2021£1,125

2022£646

2023£1,201

Investments

2011—

2012—

2013—

2014—

2017—

2018—

2021£289,034

2022£357,293

2023—

Net Assets Liabilities Including Pension Asset Liability

2011£14,615

2012£0

2013£65,731

2014£253,630

2017—

2018—

2021—

2022—

2023—

Other Investments Other Than Loans

2011—

2012—

2013—

2014—

2017—

2018—

2021£289,034

2022£357,293

2023—

Prepayments Accrued Income Not Expressed Within Current Asset Subtotal

2011—

2012—

2013—

2014—

2017£175,000

2018£0

2021—

2022—

2023—

Profit Loss Account Reserve

2011£14,613

2012£-2

2013£65,729

2014£253,628

2017—

2018—

2021—

2022—

2023—

Property Plant Equipment

2011—

2012—

2013—

2014—

2017—

2018—

2021£751

2022£1,563

2023£917

Property Plant Equipment Gross Cost

2011—

2012—

2013—

2014—

2017—

2018—

2021£6,726

2022£6,726

2023£8,005

Share Capital Allotted Called Up Paid

2011£2

2012£2

2013£2

2014£2

2017—

2018—

2021—

2022—

2023—

Shareholder Funds

2011£14,615

2012£0

2013£65,731

2014£253,630

2017—

2018—

2021—

2022—

2023—

Tangible Fixed Assets

2011£104

2012£0

2013£939

2014£470

2017—

2018—

2021—

2022—

2023—

Tangible Fixed Assets Cost Or Valuation

2011£1,734

2012£1,734

2013£1,409

2014£1,409

2017—

2018—

2021—

2022—

2023—

Tangible Fixed Assets Depreciation

2011£1,630

2012£1,734

2013£470

2014£939

2017—

2018—

2021—

2022—

2023—

Tangible Fixed Assets Depreciation Charged In Period

2011—

2012£104

2013—

2014£469

2017—

2018—

2021—

2022—

2023—

Trade Debtors Trade Receivables

2011—

2012—

2013—

2014—

2017—

2018—

2021£516

2022£516

2023£14,664

Metric	2011	2012	2013	2014	2017	2018	2021	2022	2023
Profit / (loss)	£14,613	£-2	£65,729	£253,628	—	—	—	—	—
Total assets	£14,615	£0	£65,731	£253,630	£713,455	£536,940	£451,595	£473,478	£384,061
Net Assets Liabilities	—	—	—	—	£713,455	£536,940	£451,595	£473,478	£384,061
Equity	—	—	—	—	£713,455	£536,940	£451,595	£473,478	£384,061
Current Assets	£65,550	£74,030	£128,025	£210,325	£490,784	£493,125	£204,955	£129,322	£387,114
Net Current Assets Liabilities	£14,511	£0	£64,792	£108,931	£524,238	£337,331	£161,810	£114,622	£383,144
Total Assets Less Current Liabilities	£14,615	£0	£65,731	£253,630	£715,990	£539,440	£451,595	£473,478	£384,061
Cash Bank On Hand	—	—	—	—	—	—	£204,504	£128,806	£387,114
Debtors	£26,893	£30,290	£22,038	£24,595	—	—	£451	£516	£300,590
Other Debtors	—	—	—	—	—	—	£451	—	£285,926
Creditors	—	—	—	—	£141,546	£155,794	£43,145	£14,700	£3,970
Other Creditors	—	—	—	—	—	—	£43,145	£14,700	£3,900
Investments Fixed Assets	—	—	£0	£144,229	—	—	£289,034	£357,293	—
Number Shares Allotted	—	2	—	2	—	—	—	—	—
Number Shares Issued Fully Paid	—	—	—	—	—	—	2	2	2
Par Value Share	—	£1	—	£1	—	—	£1	£1	£1
Average Number Employees During Period	—	—	—	—	—	—	1	1	1
Accrued Liabilities Not Expressed Within Creditors Subtotal	—	—	—	—	£2,535	£2,500	—	—	—
Accumulated Depreciation Impairment Property Plant Equipment	—	—	—	—	—	—	£5,163	£5,809	£7,010
Additions Other Than Through Business Combinations Property Plant Equipment	—	—	—	—	—	—	£1,937	—	£1,279
Called Up Share Capital	£2	£2	£2	£2	—	—	—	—	—
Cash Bank In Hand	£38,657	£43,740	£105,987	£185,730	—	—	—	—	—
Corporation Tax Payable	—	—	—	—	—	—	—	£70	£70
Creditors Due Within One Year	£51,039	£74,030	£63,233	£101,394	—	—	—	—	—
Depreciation Rate Used For Property Plant Equipment	—	—	—	—	—	—	£0	—	—
Fixed Assets	£104	£0	£939	£144,699	£191,752	£202,109	£289,785	£358,856	—
Increase From Depreciation Charge For Year Property Plant Equipment	—	—	—	—	—	—	£1,125	£646	£1,201
Investments	—	—	—	—	—	—	£289,034	£357,293	—
Net Assets Liabilities Including Pension Asset Liability	£14,615	£0	£65,731	£253,630	—	—	—	—	—
Other Investments Other Than Loans	—	—	—	—	—	—	£289,034	£357,293	—
Prepayments Accrued Income Not Expressed Within Current Asset Subtotal	—	—	—	—	£175,000	£0	—	—	—
Profit Loss Account Reserve	£14,613	£-2	£65,729	£253,628	—	—	—	—	—
Property Plant Equipment	—	—	—	—	—	—	£751	£1,563	£917
Property Plant Equipment Gross Cost	—	—	—	—	—	—	£6,726	£6,726	£8,005
Share Capital Allotted Called Up Paid	£2	£2	£2	£2	—	—	—	—	—
Shareholder Funds	£14,615	£0	£65,731	£253,630	—	—	—	—	—
Tangible Fixed Assets	£104	£0	£939	£470	—	—	—	—	—
Tangible Fixed Assets Cost Or Valuation	£1,734	£1,734	£1,409	£1,409	—	—	—	—	—
Tangible Fixed Assets Depreciation	£1,630	£1,734	£470	£939	—	—	—	—	—
Tangible Fixed Assets Depreciation Charged In Period	—	£104	—	£469	—	—	—	—	—
Trade Debtors Trade Receivables	—	—	—	—	—	—	£516	£516	£14,664

IMTRAPHARMA LTD

Summary

Legal & Status

Timeline (16 events)

Address updated

Status changed

Appointed Form 10 Secretaries Fd Ltd (person)

Network

Ownership & Management

Persons with significant control

Officers & directors

Ownership Timeline (2 changes)

Appointed Ray Ann, Muddle (person)

Appointed Andrew Gordon, Muddle (person)

Shareholders

Ultimate Beneficial Owner

Geography

Financials

Key figures

Documents

Company Report of IMTRAPHARMA LTD

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Companexia Document AI

Annual Accounts

Annual Accounts

Browse more companies & persons

Financial Health

Growth

Efficiency & returns

Working capital & liquidity

Capital structure